| abstract |
An object of the present invention is to provide a pharmaceutical composition containing Compound I, a pharmacologically acceptable salt thereof or a solvate thereof as an active ingredient, which has good elution in a neutral region. (A) N 1- (5-chloropyridin-2-yl) -N 2 -((1S, 2R, 4S) -4-[(dimethylamino) carbonyl] -2-{[(5- Methyl-4,5,6,7-tetrahydrothiazolo [5,4-c] pyridin-2-yl) carbonyl] amino} cyclohexyl) ethanediamide, a pharmacologically acceptable salt thereof or a solvate thereof and (B ) A pharmaceutical composition containing fumaric acid. [Selection figure] None |